Works matching DE "TRASTUZUMAB"

Results: 2957

Real‐World Efficacy of HLX02‐Based Neoadjuvant Therapy in HER2‐Positive Breast Cancer: Clinical Insights and Future Directions.

Published in:

Breast Journal, 2025, v. 2025, p. 1, doi. 10.1155/tbj/1653319

By:

Zhu, Zhengzhi;
Wang, Jing;
Hong, Shikai;
Gao, Hong;
Liu, Jianjun;
Ren, Kuojun;
Wang, Shuhan;
Wang, Shengying;
Sun, Guoping;
Sahgal, Pranshu

Publication type:

Article

The influence of H. pylori infection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathway.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1550651

By:

De Re, Valli;
Casarotto, Mariateresa;
Brisotto, Giulia;
Zanussi, Stefania;
De Zorzi, Mariangela;
Repetto, Ombretta;
Muraro, Elena;
Spessotto, Paola;
Baldo, Paolo;
Racanelli, Vito;
Lenti, Marco Vincenzo;
Venerito, Marino;
Fassan, Matteo;
Steffan, Agostino;
Realdon, Stefano;
Cannizzaro, Renato

Publication type:

Article

Case Report of Dermatomyositis With Features of the Wong Variant Developing Post‐Trastuzumab Therapy for Breast Cancer.

Published in:

Australasian Journal of Dermatology, 2025, v. 66, n. 3, p. 183, doi. 10.1111/ajd.14456

By:

LaMonica, Lauren C.;
Lang Houser, Margaret E.;
Harms, Paul W.;
Wang, Frank

Publication type:

Article

Medicare spending and use of subcutaneous biologic formulations with hyaluronidase.

Published in:

Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf149

By:

Kim, John;
Kesselheim, Aaron S;
Cliff, Edward R Scheffer;
Rome, Benjamin N

Publication type:

Article

Why Medicare Fails to Provide Access to Medically Necessary Health Care.

Published in:

Fraser Forum, 2005, p. 10

By:

Skinner, Brett J.

Publication type:

Article

HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer.

Published in:

PLoS Biology, 2010, v. 8, n. 12, p. 1, doi. 10.1371/journal.pbio.1000563

By:

Gijsen, Merel;
King, Peter;
Perera, Tim;
Parker, Peter J.;
Harris, Adrian L.;
Larijani, Banafshé;
Kong, Anthony

Publication type:

Article

Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2‐positive recurrent serous carcinoma of the uterine cervix: A case report.

Published in:

Journal of Obstetrics & Gynaecology Research, 2024, v. 50, n. 9, p. 1748, doi. 10.1111/jog.16055

By:

Yamada, Shizuka;
Orisaka, Makoto;
Kurokawa, Tetsuji;
Onuma, Toshimichi;
Shinagawa, Akiko;
Yoshida, Yoshio

Publication type:

Article

Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.

Published in:

Journal of Neuro-Oncology, 2020, v. 148, n. 1, p. 165, doi. 10.1007/s11060-020-03510-y

By:

Chen, Tom Wei-Wu;
Jan, I-Shiow;
Chang, Dwang-Ying;
Lin, Ching-Hung;
Chen, I-Chun;
Chen, Ho-Min;
Cheng, Ann-Lii;
Lu, Yen-Shen

Publication type:

Article

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1.

Published in:

2016

By:

Vries, C.;
Linn, S.;
Brandsma, D.

Publication type:

Letter

Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.

Published in:

Journal of Neuro-Oncology, 2012, v. 106, n. 1, p. 169, doi. 10.1007/s11060-011-0654-x

By:

Scodan, Romuald;
Massard, Christophe;
Jouanneau, Ludivine;
Coussy, Florence;
Gutierrez, Maya;
Kirova, Youlia;
Lerebours, Florence;
Labib, Alain;
Mouret-Fourme, Emmanuelle

Publication type:

Article

Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer.

Published in:

Journal of Neuro-Oncology, 2007, v. 85, n. 3, p. 311, doi. 10.1007/s11060-007-9420-5

By:

Rupert Bartsch;
Andrea Rottenfusser;
Catharina Wenzel;
Karin Dieckmann;
Ursula Pluschnig;
Gabriela Altorjai;
Margaretha Rudas;
Robert Mader;
Richard Poetter;
Christoph Zielinski;
Guenther Steger

Publication type:

Article

Chemotherapy for Early-Stage Breast Cancer: A Paradigm in Flux.

Published in:

Journal of Pharmacy Practice, 2008, v. 21, n. 1, p. 46, doi. 10.1177/0897190008314777

By:

Tran, Lan-phuong P.;
Grabinski, Jodi L.

Publication type:

Article

Ifosfamide: des propriétés pharmacocinétiques intéressantes pour prévenir la survenue de métastases cérébrales dans certains cancers.

Published in:

Oncologie (Tech Science Press), 2007, v. 9, n. 11, p. 790, doi. 10.1007/s10269-007-0780-4

By:

Lokiec, F.

Publication type:

Article

Les toxicités cardiovasculaires des traitements oncologiques.

Published in:

Oncologie (Tech Science Press), 2006, v. 8, n. 10, p. 901, doi. 10.1007/s10269-006-0558-0

By:

Kalou, K.;
Zelek, L.

Publication type:

Article

La chimiothérapie adjuvante: quel traitement et pour qui?

Published in:

Oncologie (Tech Science Press), 2006, v. 8, n. 8, p. 743, doi. 10.1007/s10269-006-0508-x

By:

Petit, T.

Publication type:

Article

Modalités d’utilisation et apport du trastuzumab en situation adjuvante.

Published in:

Oncologie (Tech Science Press), 2006, v. 8, n. 8, p. 748, doi. 10.1007/s10269-006-0512-1

By:

Gligorov, J.;
Belkacémi, Y.;
Azria, D.

Publication type:

Article

Sensibilité et résistance aux inhibiteurs des récepteurs Erb B.

Published in:

Oncologie (Tech Science Press), 2005, v. 7, n. 8, p. 656, doi. 10.1007/s10269-005-0320-z

By:

Delord, J.-P.;
Vignot, S.;
Milano, G.

Publication type:

Article

EORTC Protocol 16023.

Published in:: 2004
Publication type:: Other

Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study.

Published in:

Oncology, 2024, v. 102, n. 6, p. 465, doi. 10.1159/000534626

By:

Jeon, Changwan;
Kang, Su Hwan;
Kim, Sung-Bae;
Paik, Nam-Sun;
Lee, Ilkyun;
Kim, Seung Ki;
Kim, Eun Young;
Son, Gil Soo;
Yoo, Young Bum;
Lee, Kyung-Hee;
Shin, JeongSoo;
Ju, Sungil;
Jang, Harah;
Park, Min Ho

Publication type:

Article

The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic Drug.

Published in:

Oncology, 2023, v. 101, n. 12, p. 836, doi. 10.1159/000533866

By:

Jørgensen, Jan Trøst

Publication type:

Article

Sex-Specific Differences in the Risk of Heart Failure following Anti-HER2 Monoclonal Antibody Therapy.

Published in:

Oncology, 2023, v. 101, n. 6, p. 358, doi. 10.1159/000530215

By:

Suzuki, Yuta;
Kaneko, Hidehiro;
Tamura, Yuicui;
Okada, Akira;
Michihata, Nobuaki;
Jo, Taisuke;
Takeda, Norifumi;
Morita, Hiroyuki;
Fujiu, Katsuhito;
Node, Koichi;
Yasunaga, Hideo;
Komuro, Issei

Publication type:

Article

Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process.

Published in:

Oncology, 2023, v. 101, n. 4, p. 262, doi. 10.1159/000529030

By:

Dogan, Izzet;
Kizildag, Inci;
Özkurt, Selnur;
Ibis, Kamuran;
Vatansever, Sezai;
Saip, Pinar;
Aydiner, Adnan

Publication type:

Article

Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-Up of Prognostic Study Using Propensity Score Matching.

Published in:

Oncology, 2022, v. 100, n. 5, p. 257, doi. 10.1159/000522384

By:

Fujita, Noriko;
Fujita, Koichi;
Kim, Seung Jin;
Iguchi, Chikage;
Nomura, Takashi;
Aono, Toyokazu;
Yanagisawa, Tetsu;
Enomoto, Yukie;
Inakami, Keiko;
Miyagawa, Yoshimasa;
Tomoike, Riki;
Kasugai, Tsutomu;
Shiba, Eiichi

Publication type:

Article

Outcomes of Advanced Gastroesophageal Cancer Patients with Equivocal HER2 Expression with or without ERBB2 Gene Amplification.

Published in:

Oncology, 2020, v. 98, n. 12, p. 884, doi. 10.1159/000509148

By:

Abdelhakeem, Ahmed;
Wang, Xuemei;
Rogers, Jane E.;
Trail, Allison;
Zhao, Meina;
Blum-Murphy, Mariela;
Estrella, J.S.;
Ajani, Jaffer A.

Publication type:

Article

Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

Published in:

Oncology, 2020, v. 98, n. 1, p. 35, doi. 10.1159/000502910

By:

Fujita, Noriko;
Enomoto, Yukie;
Inakami, Keiko;
Yanagisawa, Tetsu;
Iguchi, Chikage;
Aono, Toyokazu;
Nomura, Takashi;
Yamamoto, Hitoshi;
Kasugai, Tsutomu;
Shiba, Eiichi

Publication type:

Article

Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib Study.

Published in:

Oncology, 2019, v. 96, n. 6, p. 309, doi. 10.1159/000497276

By:

Kojima, Yasuyuki;
Yoshie, Reiko;
Kawamoto, Hisanori;
Shimo, Arata;
Uejima, Tomoko;
Iwatani, Tsuguo;
Motoyoshi, Ai;
Kanemaki, Yoshihide;
Boku, Narikazu;
Tsugawa, Koichiro

Publication type:

Article

A Comparison between CHEK2 * 1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis.

Published in:

Oncology, 2016, v. 90, n. 4, p. 193, doi. 10.1159/000444326

By:

Huszno, Joanna;
Budryk, Magdalena;
Kołosza, Zofia;
Tęcza, Karolina;
Pamuła Piłat, Jolanta;
Nowara, Elżbieta;
Grzybowska, Ewa

Publication type:

Article

Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer.

Published in:

Oncology, 2015, v. 88, n. 6, p. 377, doi. 10.1159/000369904

By:

Yamaguchi, Takeshi;
Mukai, Hirofumi;
Yamashita, Satoshi;
Fujii, Satoshi;
Ushijima, Toshikazu

Publication type:

Article

PTEN Deficiency as a Predictive Biomarker of Resistance to HER2-Targeted Therapy in Advanced Gastric Cancer.

Published in:

Oncology, 2015, v. 88, n. 2, p. 76, doi. 10.1159/000366426

By:

Zhang, Xianglan;
Park, Ji Soo;
Park, Kyu Hyun;
Kim, Ki Hyang;
Jung, Minkyu;
Chung, Hyun Cheol;
Rha, Sun Young;
Kim, Hyo Song

Publication type:

Article

The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population.

Published in:

Oncology, 2014, v. 86, n. 1, p. 16, doi. 10.1159/000353450

By:

Adamo, Vincenzo;
Ricciardi, Giuseppina Rosaria Rita;
Adamo, Barbara;
Ferraro, Giuseppa;
Franchina, Tindara;
Rossello, Rosalba;
Zanghì, Mariangela;
Cicero, Giuseppe;
Rizzo, Sergio;
Caristi, Nicola;
Russo, Antonio

Publication type:

Article

Trastuzumab beyond Progression in Advanced Breast Cancer: National Guidance versus Oncologist's Decision.

Published in:

Oncology, 2014, v. 86, n. 1, p. 22, doi. 10.1159/000356876

By:

Wong, Han Hsi;
Collins, Jennifer;
McAdam, Karen;
Wilson, Charles

Publication type:

Article

Assessment of Adjuvant Trastuzumab-Associated Cardiac Toxicity in Korean Patients with Breast Cancer: A Single-Center Analysis.

Published in:

Oncology, 2013, v. 85, n. 4, p. 228, doi. 10.1159/000354836

By:

Cha, Chihwan;
Ahn, Sung Gwe;
Lee, Hak Min;
Lee, Hak Woo;
Lee, Seung Ah;
Jeong, Joon

Publication type:

Article

ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy.

Published in:

Oncology, 2012, v. 83, n. 4, p. 218, doi. 10.1159/000341359

By:

Kim, Ji-Won;
Kim, Jee Hyun;
Im, Seock-Ah;
Kim, Yu Jung;
Han, Hye-Suk;
Kim, Jin-Soo;
Han, Sae-Won;
Jeon, Yoon Kyung;
Oh, Do-Youn;
Han, Wonshik;
Kim, Tae-You;
Park, In Ae;
Noh, Dong-Young;
Bang, Yung-Jue

Publication type:

Article

Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology).

Published in:

Oncology, 2012, v. 83, n. 3, p. 141, doi. 10.1159/000338782

By:

Kaplan, Muhammet Ali;
Isikdogan, Abdurrahman;
Koca, Doğan;
Kucukoner, Mehmet;
Gumusay, Ozge;
Yildiz, Ramazan;
Dayan, Adem;
Demir, Lütfiye;
Geredeli, Caglayan;
Kocer, Murat;
Arslan, Ulku Yalcintas;
İnal, Ali;
Unal, Olcun Umit;
Mert, Aslıhan Guven;
Bilici, Mehmet;
Ozkan, Metin;
Elkiran, Emin Tamer;
Yaman, Sebnem;
Durnalı, Ayse Gok;
Suner, Ali

Publication type:

Article

Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers.

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 160, doi. 10.1159/000333396

By:

Huober, Jens;
Baumann, Michael;
Rochlitz, Christoph;
Aebi, Stefan;
Güth, Uwe;
von Moos, Roger;
Müller, Andreas;
von Rohr, Lukas;
Widmer, Isabelle;
Thürlimann, Beat

Publication type:

Article

Clinical Significance of PTEN and p-Akt Co-Expression in HER2-Positive Metastatic Breast Cancer Patients Treated with Trastuzumab-Based Therapies.

Published in:

Oncology, 2010, v. 78, n. 2, p. 141, doi. 10.1159/000312656

By:

Fabi, A.;
Metro, G.;
Di Benedetto, A.;
Nisticò, C.;
Vici, P.;
Melucci, E.;
Antoniani, B.;
Perracchio, L.;
Sperduti, I.;
Milella, M.;
Cognetti, F.;
Mottolese, M.

Publication type:

Article

Targeted HER2 Treatment in Advanced Gastric Cancer.

Published in:

Oncology, 2010, v. 78, n. 1, p. 26, doi. 10.1159/000288295

By:

Jørgensen, Jan Trøst

Publication type:

Article

Adjuvant Chemotherapy for the Treatment of HER2-Positive Early Breast Cancer.

Published in:

Oncology, 2009, v. 77, p. 14, doi. 10.1159/000258491

By:

Clavarezza, Matteo;
Venturini, Marco

Publication type:

Article

Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer.

Published in:

Oncology, 2009, v. 76, n. 4, p. 275, doi. 10.1159/000207504

By:

Christodoulou, Christos;
Kostopoulos, Ioannis;
Kalofonos, Haralabos P.;
Lianos, Evangelos;
Bobos, Mattheos;
Briasoulis, Evangelos;
Gogas, Helen;
Razis, Evangelia;
Skarlos, Dimosthenis V.;
Fountzilas, George

Publication type:

Article

Targeting Her-2/neu in Breast Cancer: As Easy as This!

Published in:

Oncology, 2008, v. 74, n. 3/4, p. 150, doi. 10.1159/000151362

By:

Azim, Hamdy;
Azim Jr., Hatem A.

Publication type:

Article

Vascular Endothelial Growth Factor Partially Inhibits the Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity of Human Monocytes.

Published in:

Oncology, 2007, v. 72, n. 3/4, p. 172, doi. 10.1159/000112803

By:

Mimura, Kousaku;
Kono, Koji;
Takahashi, Akihiro;
Kawaguchi, Yoshihiko;
Mizukami, Yoshiki;
Fujii, Hideki

Publication type:

Article

Non-drug related costs of treatment with pertuzumab and trastuzumab in HER2-positive breast cancer patients in Poland.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 181, doi. 10.5603/ocp.97426

By:

Seweryn, Michał;
Banaś, Tomasz;
Augustyńska, Joanna;
Leszczyńska, Agnieszka;
Potocki, Paweł M.

Publication type:

Article

Home-based treatment with subcutaneous trastuzumab: safe and acceptable not only during a pandemic -- final analysis of the RWD project 'FlexCare'.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 2, p. 117, doi. 10.5603/OCP.2023.0025

By:

Radecka, Barbara;
Hudała-Klecha, Joanna;
Sawka, Dariusz;
Sarga, Jolanta;
Noworolska, Bożena;
Susczyk, Grażyna;
Sawicka, Jolanta;
Duda, Elżbieta;
Obruśnik, Natalia;
Zając, Patryk

Publication type:

Article

Commentary: on Trastuzumab deruxtecan in the treatment of adult patients with HER-positive breast cancer.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 5, p. 382, doi. 10.5603/ocp.97613

By:

Krzakowski, Maciej

Publication type:

Article

Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 5, p. 377, doi. 10.5603/ocp.97612

By:

Kufel-Grabowska, Joanna

Publication type:

Article

Pathological complete response and survival of HER2-positive invasive breast cancer following docetaxel, carboplatin, and trastuzumab neoadjuvant therapy: a Vietnamese experience.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 4, p. 235, doi. 10.5603/OCP.2023.0020

By:

Duc Thanh Le;
Tu Anh Do;
Lap Thanh Bui;
Kien Hung Do;
Chu Van Nguyen

Publication type:

Article

Case report of radiation-induced lung injury with trastuzumab emtansine: the lung also matters.

Published in:

Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 6, p. 415, doi. 10.5603/OCP.2022.0043

By:

Gurlek, Ezgi;
Yilmaz, Melek Tugce;
Gultekin, Melis;
Aksoy, Sercan;
Yildiz, Ferah

Publication type:

Article

Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries.

Published in:

JAMA Network Open, 2021, v. 4, n. 2, p. e210030, doi. 10.1001/jamanetworkopen.2021.0030

By:

Green, Angela K.;
Curry, Michael;
Trivedi, Niti;
Bach, Peter B.;
Mailankody, Sham

Publication type:

Article

Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer.

Published in:

JAMA Network Open, 2020, v. 3, n. 11, p. e2027074, doi. 10.1001/jamanetworkopen.2020.27074

By:

Kunst, Natalia;
Wang, Shi-Yi;
Hood, Annette;
Mougalian, Sarah S.;
DiGiovanna, Michael P.;
Adelson, Kerin;
Pusztai, Lajos

Publication type:

Article

Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01845-3

By:

El Alaoui, Meddy;
Sivado, Eva;
Jallas, Anne-Catherine;
Mebarki, Lamia;
Dyson, Michael R.;
Perrez, Franck;
Valsesia-Wittmann, Sandrine;
El Alaoui, Said

Publication type:

Article